708253-33-2Relevant academic research and scientific papers
TUBULIN INHIBITORS
-
Page/Page column 38-39, (2008/06/13)
Compounds of general formula (I), (II) (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also described. Further described are novel compounds of formula (II), (III) and (V).
PYRAZINE-BASED TUBULIN INHIBITORS
-
Page 27, (2010/02/07)
A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating a hyperproliferation-related disease state or disorder in a subject using a compound of formula (I) is also described
